(Q52992774)

10 May 2018

title

A modification of the JAM test is necessary for a correct determination of apoptosis induced by FasL+ adherent tumor cells. (English)

1 reference

10 May 2018

author

Alexei Gratchev

3

1 reference

10 May 2018

author name string

Böhm C

1

1 reference

10 May 2018

Hanski ML

2

1 reference

10 May 2018

Mann B

4

1 reference

10 May 2018

Moyer MP

5

1 reference

10 May 2018

Riecken EO

6

1 reference

10 May 2018

Hanski C

7

1 reference

10 May 2018

publication date

1 August 1998

1 reference

10 May 2018

Journal of Immunological Methods

published in

1 reference

10 May 2018

volume

217

1 reference

10 May 2018

issue

1-2

1 reference

10 May 2018

page(s)

71-78

1 reference

10 May 2018

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

A role for CD95 ligand in preventing graft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Human tumor antigens recognized by T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Fas-ligand: privilege and peril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

The role of FasL-induced apoptosis in immune privilege

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Activated B cells express functional Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Fas and FasL in the homeostatic regulation of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

The JAM test. A simple assay for DNA fragmentation and cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Fas involvement in cytotoxicity mediated by human NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

NCM460, a normal human colon mucosal epithelial cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Apoptosis by death factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Cancer vaccines based on the identification of genes encoding cancer regression antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Antitumor effect of locally produced CD95 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Expression of Fas ligand in liver metastases of human colonic adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Development and characterization of normal colonic epithelial cell lines derived from normal mucosa of patients with colon cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900100-8

10.1016/S0022-1759(98)00100-8

7 January 2021

Identifiers

DOI

1 reference

10 May 2018

PubMed ID

9776576

1 reference

10 May 2018